{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:26:27Z","timestamp":1785522387194,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1007\/bf01271201","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T04:54:13Z","timestamp":1111640053000},"page":"1163-1175","source":"Crossref","is-referenced-by-count":43,"title":["Antipsychotics with inverse agonist activity at the dopamine D3 receptor"],"prefix":"10.1007","volume":"103","author":[{"given":"N.","family":"Griffon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sautel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. -C.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sokoloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/bj3030803","volume":"303","author":"EJ Adie","year":"1994","unstructured":"Adie EJ, Milligan G (1994) Regulation of basal adenylate cyclase activity in neuroblastoma X glioma hybrid, NG 108-15, cells transfected to express the human ?2 adrenoceptor: evidence for empty receptor stimulation of the adenylate cyclase cascade. Biochem J 303: 803?808","journal-title":"Biochem J"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1016\/S0021-9258(17)32625-X","volume":"269","author":"EL Barker","year":"1994","unstructured":"Barker EL, Westphal RS, Schmidt D, Sanders-Bush E (1994) Constitutively active 5-hydroxytryptamine 2c receptors reveal novel inverse agonist activity of receptors ligands. J Biol Chem 269: 11687?11690","journal-title":"J Biol Chem"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/374272a0","volume":"374","author":"AR Bond","year":"1995","unstructured":"Bond AR, P. Leff TD, Johnson CA, Milano HA, Rockman TR, McMinn S, Apparsundaram MF, Hyek TP, Kenakin LF, Allen LF, Lefkowitz RJ (1995) Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the ?2-adrenoreceptor. Nature 374: 272?276","journal-title":"Nature"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"9921","DOI":"10.1073\/pnas.90.21.9921","volume":"90","author":"C Boone","year":"1993","unstructured":"Boone C, Davis NG, Sprague GF (1993) Mutations that alter the third cytoplasmic loop of the a-factor receptor lead to a constitutive and hypersensitive phenotype. Proc Natl Acad Sci USA 90: 9921?9925","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","first-page":"490","volume":"45","author":"P Chidiac","year":"1994","unstructured":"Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M (1994) Inverse agonist activity of ?-adrenergic antagonists. Mol Pharmacol 45: 490?499","journal-title":"Mol Pharmacol"},{"key":"CR6","first-page":"51","volume":"45","author":"CL Chio","year":"1994","unstructured":"Chio CL, Lajiness ME, Huff RM (1994) Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol Pharmacol 45: 51?60","journal-title":"Mol Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1073\/pnas.86.19.7321","volume":"86","author":"TH Costa","year":"1989","unstructured":"Costa TH, Herz A (1989) Antagonists with negative intrinsic activity at opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86: 7321?7325","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR8","first-page":"549","volume":"41","author":"T Costa","year":"1992","unstructured":"Costa T, Ogino Y, Munson PJ, Oranan HO, Rodbard D (1992) Drug efficacy at guanine nucleotide-binding regulatory protein linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol 41: 549?560","journal-title":"Mol Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1073\/pnas.87.8.2896","volume":"87","author":"S Cotecchia","year":"1990","unstructured":"Cotecchia S, Exum S, Caron MG, Lefkowitz RJ (1990) Regions of the ?1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA 87: 2896?2900","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1016\/S0021-9258(20)79672-9","volume":"255","author":"A DeLean","year":"1980","unstructured":"DeLean A, Stadel JM, Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled ?-adrenergic receptor. J Biol Chem 255: 7108?7117","journal-title":"J Biol Chem"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0306-4522(94)00527-C","volume":"65","author":"J Diaz","year":"1995","unstructured":"Diaz J, L\ufffdvesque D, Lammers CH, Griffon N, Martres M-P, Schwartz J-C, Sokoloff P (1995) Phenotypical characterization of neurons expressing the dopamine D3 receptor. Neuroscience 65: 731?745","journal-title":"Neuroscience"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ng0794-396","volume":"7","author":"L Duprez","year":"1994","unstructured":"Duprez L, Parma J, Van Sande J, Allgeier A, Lecl\ufffdre J, Schvartz C, Deliste MJ, Decoulx M, Orgiazzi J, Dunont J, Vassart G (1994) Germline mutations in the tyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet 7: 396?401","journal-title":"Nature Genet"},{"key":"CR13","first-page":"417","volume":"268","author":"SB Freedman","year":"1994","unstructured":"Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G (1994) Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther 268: 417?426","journal-title":"J Pharmacol Exp Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0014-2999(95)00460-3","volume":"282","author":"N Griffon","year":"1995","unstructured":"Griffon N, Pilon C, Schwartz J-C, Sokoloff P (1995) The preferential dopamine D3 receptor ligand (+)UH 232 is a partial agonist. Eur J Pharmacol 282: R3-R4","journal-title":"Eur J Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bst0240193","volume":"24","author":"N Griffon","year":"1996","unstructured":"Griffon N, Sautel F, Pilon C, L\ufffdvesque D, Sokoloff P, Schwartz J-C, Diaz J, Simon P, Costentin J, Mann A, Wermuth CG (1996) Functional models for the dopamine D3 receptor. Biochem Soc Trans 24: 193?198","journal-title":"Biochem Soc Trans"},{"key":"CR16","unstructured":"Gurevich V, Kung MP, Bordelon Y, Joyce JN (1994) Dopamine D3 receptors are elevated in mesolimbic dopamine system of schizophrenics: receptor autoradiographic studies. Neuropsychopharmacol 10: 236S"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0021-9258(18)45962-5","volume":"267","author":"MA Kjelsberg","year":"1992","unstructured":"Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz R (1992) Constitutive activation of the ?1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267: 1430?1433","journal-title":"J Biol Chem"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-6147(00)88989-0","volume":"16","author":"P Leff","year":"1995","unstructured":"Leff P (1995) The two-state model of receptor activation. Trends Pharmacol Sci 16: 89?97","journal-title":"Trends Pharmacol Sci"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0922-4106(94)90212-7","volume":"266","author":"RG MacKenzie","year":"1994","unstructured":"MacKenzie RG, Van Leeuwen D, Pugsley TA, Shih YH, Demattos S, Tang L, Todd RD, O'Malley K (1994) Characterization of the human dopamine D3 receptor expressed in transfected cell lines. Eur J Pharmacol Mol Pharmacol Sect 266: 79?85","journal-title":"Eur J Pharmacol Mol Pharmacol Sect"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-6147(00)88963-4","volume":"16","author":"G Milligan","year":"1995","unstructured":"Milligan G, Bond RA, Lee M (1995) Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16: 10?13","journal-title":"Trends Pharmacol Sci"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/365649a0","volume":"365","author":"J Parma","year":"1993","unstructured":"Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dunont J, Vassart G (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649?651","journal-title":"Nature"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0922-4106(94)90182-1","volume":"268","author":"C Pilon","year":"1994","unstructured":"Pilon C, L\ufffdvesque D, Dimitriadou V, Griffon N, Martres MP, Schwartz J-C, Sokoloff P (1994) Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur J Pharmacol [Mol Pharmacol Sect] 268: 129?139","journal-title":"Eur J Pharmacol [Mol Pharmacol Sect]"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/367639a0","volume":"367","author":"RV Rao","year":"1994","unstructured":"Rao RV, Cohen GB, Oprian DD (1994) Rhodopsin mutation G90D and a molecular mechanism for congenital right blindness. Nature 367: 639?642","journal-title":"Nature"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"16483","DOI":"10.1016\/S0021-9258(19)85445-5","volume":"268","author":"Q Ren","year":"1993","unstructured":"Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S (1993) Constitutively active mutants of the alpha-2-adrenergic receptor. J Biol Chem 268: 16483?16487","journal-title":"J Biol Chem"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(93)90572-8","volume":"72","author":"LS Robbins","year":"1993","unstructured":"Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, Mountjoy KG, Cone RD (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72: 827?834","journal-title":"Cell"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0896-6273(92)90034-B","volume":"9","author":"PR Robinson","year":"1992","unstructured":"Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD (1992) Constitutively active mutants of rhodopsin. Neuron 9: 719?725","journal-title":"Neuron"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/S0021-9258(18)53442-6","volume":"268","author":"P Samama","year":"1993","unstructured":"Samama P, Cotecchia S, Costa T, Lefkowitz RJ (1993) A mutation-induced activated state of the ?2-adrenergic receptor. J Biol Chem 268: 4625?4636","journal-title":"J Biol Chem"},{"key":"CR28","first-page":"390","volume":"45","author":"P Samama","year":"1994","unstructured":"Samama P, Pei G, Costa T, Cotecchia S, Lefkowitz RJ (1994) Negative antagonists promote an inactive conformation of the ?2-adrenergic receptor. Mol Pharmacol 45: 390?394","journal-title":"Mol Pharmacol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00001756-199501000-00026","volume":"6","author":"F Sautel","year":"1995","unstructured":"Sautel F, Griffon N, L\ufffdvesque D, Pilon C, Schwartz JC, Sokoloff P (1995a) A functional test identifies dopamine agonists selective for D3 versus D2 receptors. NeuroReport 6: 329?332","journal-title":"NeuroReport"},{"key":"CR30","first-page":"1239","volume":"275","author":"F Sautel","year":"1995","unstructured":"Sautel F, Griffon N, Sokoloff P, Schwartz J-C, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A, Wermuth CG (1995b) Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275: 1239?1246","journal-title":"J Pharmacol Exp Ther"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-5793(92)80918-7","volume":"312","author":"GR Seabrook","year":"1992","unstructured":"Seabrook GR, Patel S, Marwood R, Emms F, Knowles MR, Freedman SB, McAllister G (1992) Stable expression of human D3 dopamine receptor in GH4C1 pituitary cells. FEBS Lett 312: 123?126","journal-title":"FEBS Lett"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/365652a0","volume":"365","author":"A Shenker","year":"1993","unstructured":"Shenker A, Lane L, Kosugi S, Merendino JJ, Minegishi T, Cutler GB (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365: 652?654","journal-title":"Nature"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0165-6147(00)89044-6","volume":"16","author":"P Sokoloff","year":"1995","unstructured":"Sokoloff P, Schwartz JC (1995) The novel dopamine receptors half a decade later. Trends Pharmacol Sci 16: 270?275","journal-title":"Trends Pharmacol Sci"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","volume":"347","author":"P Sokoloff","year":"1990","unstructured":"Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwartz J-C (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146?151","journal-title":"Nature"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0922-4106(92)90107-7","volume":"225","author":"P Sokoloff","year":"1992","unstructured":"Sokoloff P, Andrieux M, Besan\ufffdon R, Pilon C, Martres M-P, Giros B, Schwartz J-C (1992) Pharmacology of human D3 dopamine receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol Mol Pharmacol Sect 225: 331?337","journal-title":"Eur J Pharmacol Mol Pharmacol Sect"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(94)90718-8","volume":"263","author":"K Svensson","year":"1994","unstructured":"Svensson K, Carlsson A, Huff RM, Kling-Petersen T, Waters N (1994) Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 263: 235?243","journal-title":"Eur J Pharmacol"},{"key":"CR37","first-page":"495","volume":"268","author":"L Tang","year":"1994","unstructured":"Tang L, Todd RD, Heller A, O'Malley KL (1994) Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblasts and dopaminergic cell lines. J Pharmacol Exp Ther 268: 495?502","journal-title":"J Pharmacol Exp Ther"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"27925","DOI":"10.1016\/S0021-9258(18)46876-7","volume":"269","author":"M Tiberi","year":"1994","unstructured":"Tiberi M, Caron MG (1994) High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269: 27925?27931","journal-title":"J Biol Chem"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01271201\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:08:19Z","timestamp":1625638099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01271201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["BF01271201"],"URL":"https:\/\/doi.org\/10.1007\/bf01271201","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}